16.00
price up icon0.69%   0.11
after-market Handel nachbörslich: 16.00
loading

Finanzdaten der Centessa Pharmaceuticals Plc Adr-Aktie (CNTA)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Interest Income/Expense
1.60%
2.529
2.57 2.541 2.45 2.345
Operating Income/Loss
2.59%
-36.09
-35.18 -40.21 -47.02 -48.88
Income/Loss From Continuing Operations Before Tax
5.24%
-37.56
-35.69 -41.47 -48.94 -50.04
Income Tax Expense/Benefit, Deferred
391.28%
0.434
-0.149 -2.89 - -
Income Tax Expense/Benefit
57.95%
0.481
1.144 -2.826 -24.05 0.677
Income/Loss From Continuing Operations After Tax
3.28%
-38.05
-36.84 -38.65 -24.89 -50.71
Net Income/Loss
3.28%
-38.05
-36.84 -38.65 -24.89 -50.71
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
16,876%
99.89
0.5884 96.65 95.16 94.94
Diluted Average Shares
16,876%
99.89
0.5884 96.65 95.16 94.94
Basic Earnings Per Share
2.70%
-0.38
-0.37 -0.40 -0.26 -0.53
Diluted Earnings Per Share
2.70%
-0.38
-0.37 -0.40 -0.26 -0.53
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
Kapitalisierung:     |  Volumen (24h):